Series
ELSIconversations Series 2 - Spring 2022
Standardizing Lab Requisition Forms for Hypertrophic Cardiomyopathy (HCM): A ClinGen Cardiovascular Disease Working Group Initiative
Ana Morales, MS, CGC
ADWG ELSIconversations Session 3 - May 20, 2022
Question: If changes to these forms were to be recommended, what are the considerations that need to be made to implement these changes? Barriers/opportunities?
Goal: Identify the considerations necessary to change these clinical forms
Tags
Keywords
clinical lab requisition forms
Hypertrophic Cardiomyopathy
Videos in Series
-
ELSIconversations Series 2 - Spring 2022 - ELSIconversations: Revisions to Demographic Representations on Clinical Lab Requisition Forms
-
ELSIconversations Series 2 - Spring 2022 - Challenges in Implementing Changes in the Collection of Race, Ethnicity, and Ancestry Data in Test Requisition Forms
-
ELSIconversations Series 2 - Spring 2022 - ELSIconversations: Utility of Population Descriptors in Clinical Genetics
-
ELSIconversations Series 2 - Spring 2022 - ELSIconversations: Shedding Light on the Use of Population Descriptors in Clinical Genetics
-
ELSIconversations Series 2 - Spring 2022 - How Race, Ethnicity, and Ancestry Information is Used in Genetic Diagnostics: One Lab's Perspective
-
ELSIconversations Series 2 - Spring 2022 - Diversity Measures in Genomic Medicine
-
ELSIconversations Series 2 - Spring 2022 - Clinical Genetics Laboratories Use Divergent Demographic Frameworks Across Countries
-
ELSIconversations Series 2 - Spring 2022 - Shedding Light on the Use of Population Descriptors in Clinical Genetics
-
ELSIconversations Series 2 - Spring 2022 - Race, Ethnicity, and Ancestry (REA) in Clinical Genetics: Variability in Collection and Use
-
ELSIconversations Series 2 - Spring 2022 - The Challenges of Standardization in a System with Complex Incentives